Cimetidine modulates the antigen presenting capacity of dendritic cells from colorectal cancer patients

Cimetidine, a H(2) receptor antagonist, has been reported to improve survival in gastrointestinal cancer patients. These effects have largely been attributed to the enhancing effects of cimetidine on the host's antitumour cell-mediated immune response, such as inhibition of suppressor T lymphoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubota, T, Fujiwara, H, Ueda, Y, Itoh, T, Yamashita, T, Yoshimura, T, Okugawa, K, Yamamoto, Y, Yano, Y, Yamagishi, H
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2002
Materias:
Molecular and Cellular Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375332/
https://www.ncbi.nlm.nih.gov/pubmed/11953882
http://dx.doi.org/10.1038/sj.bjc.6600233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375332/
https://www.ncbi.nlm.nih.gov/pubmed/11953882
http://dx.doi.org/10.1038/sj.bjc.6600233

Ejemplares similares